What is it about?
The study evaluates the level of adherence to treatment using a newly developed scale (ACDS) in patients after MI treated with percutaneous coronary intervention.
Featured Image
Why is it important?
The physician-patient collaboration and adherence to recommended treatment is essential to achieve intended therapeutic effect. Nonadherence to medication regimen after myocardial infarction (MI) leads to increased morbidity and mortality and generates additional cost to the health care system. The Adherence in Chronic Diseases Scale (ACDS) is a newly developed, validated method for assessment of adherence to treatment in chronically ill patients.
Perspectives
The failure to follow treatment recommendations in patients after MI may be catastrophic. Nonadherence to treatment results in therapeutic failures, increased complications rate, and rising costs of treatment. The ACDS-based identification of patients at high risk for nonadherence and its causes allows the implementation of personalized strategies for adherence improvement including educational interventions.
Aldona Kubica
Nicolaus Copernicus University
Read the Original
This page is a summary of: Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction, Patient Preference and Adherence, March 2018, Dove Medical Press,
DOI: 10.2147/ppa.s150435.
You can read the full text:
Contributors
The following have contributed to this page
